38 results

• Gilead Claims Twice-Annual Injection Better At Preventing HIV Than Daily PrEP Pill

  September 23, 2024

  Irvin Jackson

  Drug maker says twice-yearly injection could be more effective at preventing HIV infections than Truvada, which is a daily PrEP pill that has been linked to reports of kidney injuries, bone fractures and other concerns.

• Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M

  June 12, 2024

  Irvin Jackson

  Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.

• TDF Lawsuit Filed Against Gilead Over Toxic Side Effects of Truvada, Atripla, Other HIV Drugs

  March 27, 2024

  Irvin Jackson

  A TDF lawsuit filed by 26 plaintiffs claims Gilead purposefully exposed them to increased kidney disease and bone fracture risks from its older HIV drugs to increase profits.

• Lawsuits Over Truvada, Other TDF-Based HIV Drugs Cleared To Move Forward By Appeals Court

  January 12, 2024

  Irvin Jackson

  A California appeals court has cleared the way for 24,000 lawsuits over Truvada and other TDF-based Gilead HIV drugs to proceed on claims of negligence.

• HIV Drug Descovy May Increase Risk of High Blood Pressure: Study

  September 22, 2023

  Irvin Jackson

  Kaiser Permanente researchers warn that the side effects of Descovy could result in an increased risk of hypertension and the need for cholesterol control.

• Appeals Court Weighs Gilead Challenge to Lawsuits Over Delaying HIV Drug Development

  September 5, 2023

  Irvin Jackson

  A California appeals court is weighing whether Gilead had a responsibility to develop safer HIV drugs to replace older ones with a higher risk of kidney damage and bone fractures.

• Lawsuit Against Truvada, Viread Maker Alleges TDF-Based HIV Drugs Toxic to Users Kidneys, Bones

  June 6, 2023

  Irvin Jackson

  Nearly 20 plaintiffs have filed a lawsuit against Gilead, saying it failed to warn patients its TDF-based HIV drugs could cause bone and kidney problems.

• Gilead Faces Bone Demineralization Lawsuit Over Truvada, Other TDF-Based HIV Drugs

  April 13, 2023

  Irvin Jackson

  A lawsuit filed by two different plaintiffs say they suffered bone density loss due to the side effects of Gilead TDF-based HIV drugs.

• Lawsuit Alleges Side Effects of Atripla, Stribild and Other HIV Drugs Endangered Patients to Increase Gilead Profits

  October 5, 2022

  Irvin Jackson

  A lawsuit filed by 20 plaintiffs claims Gilead held back safer formulations of its HIV drugs in order to maximize profits at the expense of their kidneys and other health risks.

• Gilead HIV Drug Health Risks Were Known Before First TDF-Based Antiretrovirals Hit The Market: Lawsuit

  February 7, 2022

  Irvin Jackson

  Gilead knew its HIV drugs carried severe health risks before the first ones were placed on the market, the lawsuit claims.